Osaic Holdings’s Moderna MRNA Stock Holding History

Osaic Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15	Closed	-$14.9K	–	7551
2024 Q3	$14.9K	Hold	15	–	–	﹤0.01%	5554
2024 Q2	$14.9K	Buy	15 +14	+1,400%	+$1.77K	﹤0.01%	5541
2024 Q1	$35	Sell	1 -1	-50%	-$101	﹤0.01%	7098
2023 Q4	$7	Hold	2	–	–	﹤0.01%	7245
2023 Q3	$146	Hold	2	–	–	﹤0.01%	7190
2023 Q2	$856	Hold	2	–	–	﹤0.01%	6921
2023 Q1	$3.38K	Hold	2	–	–	﹤0.01%	6510
2022 Q4	$7K	Hold	2	–	–	﹤0.01%	6135
2022 Q3	$3K	Hold	2	–	–	﹤0.01%	6637
2022 Q2	$4K	Hold	2	–	–	﹤0.01%	6607
2022 Q1	$8K	Hold	2	–	–	﹤0.01%	6274
2021 Q4	$26K	Buy	2 +1	+100%	+$292	﹤0.01%	5616
2021 Q3	$35K	Hold	1	–	–	﹤0.01%	5381
2021 Q2	$20K	Hold	1	–	–	﹤0.01%	5663
2021 Q1	$10K	Hold	1	–	–	﹤0.01%	5873
2020 Q4	$7K	Hold	1	–	–	﹤0.01%	5660
2020 Q3	$5K	Hold	1	–	–	﹤0.01%	5570
2020 Q2	$4K	Buy	+1	New	+$55	﹤0.01%	5573

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings's MRNA Position: Q1 2026 in Review

Osaic Holdings reduced its Moderna (MRNA) stake by 8.3% in Q1 2026, selling an estimated $169K and leaving 40,197 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

Osaic Holdings first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $65.1M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Osaic Holdings held 40,197 shares of Moderna worth $2.04M as of Q1 2026.
Osaic Holdings sold 3,627 Moderna shares in Q1 2026, an estimated $169K.
Moderna made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2060 holding.
Osaic Holdings first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
Osaic Holdings's Moderna position peaked at $65.1M in Q3 2021.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.